Pharma channel feed

France stops Val­neva's chikun­gun­ya vac­cine roll­out in over 65s af­ter safe­ty is­sue

4 weeks ago

GSK’s check­point block­er Jem­per­li cures bio­mark­er-dri­ven rec­tal can­cer

4 weeks ago
R&D

FDA chief Makary talks ex­pe­dit­ing drug ap­provals, RIFs and the abor­tion pill

5 weeks ago
R&D
FDA+

Ab­b­Vie com­mits $10B to ex­pand US foot­print with the threat of tar­iffs ahead

5 weeks ago
Manufacturing

Com­pound­ing phar­ma­cies dealt a blow in fight over end of semaglu­tide short­age

5 weeks ago
Law
Health Tech

RFK Jr. touts CMS pro­gram test­ing new ways to pay for sick­le cell dis­ease treat­ment

5 weeks ago
Cell/Gene Tx

Ab­b­Vie's im­munol­o­gy fran­chise re­mains a pow­er­house, as Skyrizi, Rin­voq com­bine for $5B

5 weeks ago

Mer­ck KGaA clos­es in on Spring­Works deal at $3.5B price point

5 weeks ago
Deals

Gilead­'s strong HIV busi­ness bal­ances out low Covid and can­cer drug sales

5 weeks ago

Mer­ck is ‘well-po­si­tioned’ on Keytru­da ahead of threat­ened phar­ma tar­iffs, CEO says

5 weeks ago

On­ly two-thirds of FDA-ap­proved biosim­i­lars have launched, re­port finds

5 weeks ago
FDA+

Drug­mak­ers see a sub­stan­tial, but man­age­able, hit to busi­ness from tar­iffs. But the worst may lie ahead

5 weeks ago
China

Cas­sidy urges con­gres­sion­al re­forms to 340B drug dis­count pro­gram af­ter in­ves­ti­ga­tion

5 weeks ago
FDA+

Halozyme sues Mer­ck, al­leg­ing in­jectable Keytru­da will in­fringe its patents

5 weeks ago
Law

Bris­tol My­ers CEO sig­nals deal­mak­ing will be a top pri­or­i­ty in 2025

Last month
Deals

Bris­tol My­er­s' tran­si­tion moves for­ward as it rais­es 2025 rev­enue fore­cast

Last month

Ther­mo Fish­er buck­les up for US-Chi­na trade war, bud­gets $2B to ease im­pact

Last month
China
Manufacturing

Roche takes steps to pro­tect it­self from tar­iffs, while Sanofi hangs back

Last month

Mer­ck’s Gar­dasil sales sink fur­ther amid Chi­na mar­ket pres­sure

Last month
China

Sanofi's Al­tuvi­i­io clos­ing in on block­buster sta­tus, Dupix­ent sales surge

Last month
R&D

Roche CEO warns that tar­iffs could im­pact deal­mak­ing

Last month
Deals

As­traZeneca CEO says Eu­rope is 'falling be­hind' on R&D and man­u­fac­tur­ing in­vest­ments

Last month
People

Large vac­cine mak­ers stand by their in­vest­ments de­spite US head­winds

Last month
FDA+

Top phar­ma com­pa­nies in­creased lob­by­ing spend in first quar­ter of 2025

Last month
FDA+
Law
First page Previous page 3456789 Next page Last page
A service from the Financial Times